About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

Prostate Cancer & Sexuality Survey

The Australian Research Centre in Sex, Health and Society at La Trobe University, Melbourne, Australia is conducting an international survey of men’s experiences of sexual activity following treatment for prostate cancer. The aims of this survey include the following: * To learn more about how men adapt their sexual activities to prostate cancer treatments * [...]

By |2011-01-27T08:33:04-05:00January 27th, 2011|Treatment News|1 Comment

Healing and Support – The Goal of A Cancer Support Group

On the heels of that terrible attack in Arizona there has been a lot of conversation in the media about healing. This has been a time of deep distress across the country with many images in the media of actions and reactions from all sorts of people. It is events like this one that points [...]

A New Strategey – Fight Cancer with Cancer – On The Horizon

Thinking out of the box, a new concept to fight cancer, including prostate cancer, has been developed. The strategy is simple, fight cancer with cancer! In a very small phase one trial researchers at the Rogosin Institute have taken encapsulated tumor cells from mice and made a bead from a seaweed-derived sugar called agarose. Then, [...]

Your Oncologist and Getting Their Cooperation In Using Out Of The Box Treatments

For those who do not know, I moderate an advanced prostate cancer on-line support group. Members are both men with advanced prostate cancer and many of their care givers. There was a recent conversation I want to share about specific “off label” and “out of the box” treatment strategies, specifically about oncologists not knowing about [...]

Abiraterone Acetate Now Available in the North East, United States

From Jan Manarite: To all, Many of you who have advanced prostate cancer may have been watching a drug in development called Abiraterone Acetate. It is not yet FDA approved, but trials look very good, and side effects appear to be very few. Most common side effects are fluid retention (30.5%), and low potassium (17.1%). [...]

Go to Top